JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis

Stock Information for Nuwellis Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Nuwellis Inc.

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results
Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO
Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025
Nuwellis Adds Nationally Ranked Utah Hospital as New Pediatric Customer for Aquadex SmartFlow® Therapy
Nuwellis Regains Compliance with Nasdaq Listing Requirements
Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights
Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds
Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.